Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 9, 2011, Pages 1200-1206

  Brun Buisson, Christian ^a,b,c   Richard, Jean Christophe M ^d   Mercat, Alain ^e   Thiébaut, Anne C M ^c,f   Brochard, Laurent ^a,b,g  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f University Versailles Saint Quentin UVSQ   (France)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute respiratory failure; Corticosteroid therapy; Host defenses; Pandemic influenza; Viral pneumonia

Indexed keywords

HYDROCORTISONE; HYPERTENSIVE FACTOR; NITRIC OXIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; EMERGENCY TREATMENT; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PNEUMONIA; PRIORITY JOURNAL; REGISTER; SCORING SYSTEM; TREATMENT INDICATION;

EID: 79955505106     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201101-0135OC     Document Type: Article

References (28)

1. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008;336:1006-1009.
2. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37:1594-1603.
3. Chen RC, Tang XP, Tan SY, Liang BL, Wan ZY, Fang JQ, Zhong N. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest 2006;129:1441-1452.
4. Sung JJ, Wu A, Joynt GM, Yuen KY, Lee N, Chan PK, Cockram CS, Ahuja AT, Yu LM, Wong VW, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004;59:414-420.
5. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006;3:e343.
6. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374-1385.
7. Jung K, Alekseev KP, Zhang X, Cheon DS, Vlasova AN, Saif LJ. Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. J Virol 2007;81:13681-13693.
8. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007;104:12479-12481.
9. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, et al., The ANZIC Influenza investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361: 1925-1934.
10. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-1879.
11. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, Meduri GU. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36:33-41.
12. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, Chiche JD, Barahona D, Villabon M, Balasini C, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011;37:272-283.
13. Xi X, Xu Y, Jiang L, Li A, Duan J, Du B. Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis 2010;10:256.
14. Fuhrman C, Bonmarin I, Bitar D, Cardoso T, Duport N, Herida M, Isnard H, Guidet B, Mimoz O, Richard JC, et al. Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection. Epidemiol Infect 2010;26:1-8.
15. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson LD, Lamy M, Le Gall JR, Morris AH, Spragg R. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trials coordination. Am J Respir Crit Care Med 1994;149:818-824.
16. Brun-Buisson C, Richard J-CM, Mercat A, Brochard L, for the REVAGRIPPE- SRLF Registry. Corticosteroid therapy in early ARDS secondary to Influenza A/H1N1 (2009) pneumonia: data from the REVA-SRLF Registry [abstract]. Intensive Care Med 2010;36:S237.
17. Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005;31:1345-1355.
18. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710-718.
19. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-1684.
20. Giannella M, Alonso M, Garcia de Viedma D, Roa PL, Catalan P, Padilla B, Muñoz P, Bouza E. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (In press)
21. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:971-973.
22. Roberts C, Nirmalan M, O'Shea S. Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). Am J Respir Crit Care Med 2010;182:1089-1090.
23. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer- Muram HT, Khare V, Eltorky M. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 1994;105:1516-1527.
24. Meduri GU, Headley AS, Golden H, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 1998;280:159-165.
25. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-963.
26. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006;34:22-30.
27. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 2009;136:1631-1643.
28. Diaz JV, Brower R, Calfee CS, Matthay MA. Therapeutic strategies for severe acute lung injury. Crit Care Med 2010;38:1644-1650.